NCT02553213

Brief Summary

The aim of the study is to investigate, if bariatric surgery or the related caloric restriction causes the significant improvement of glucose metabolism, which has been found in bariatric patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 4, 2015

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 17, 2015

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2019

Completed
Last Updated

May 17, 2018

Status Verified

May 1, 2018

Enrollment Period

3.8 years

First QC Date

September 4, 2015

Last Update Submit

May 14, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change of insulin

    Blood insulin is measured during a Mixed Meal Tolerance Test (MMTT). It is used to calculate the Homeostasis Model Assessment (HOMA) and Matsuda Insulin Sensitivity Index

    Within 5 days after surgery or 5 days after start of caloric restriction

  • Change of blood glucose

    Blood glucose is measured during a Mixed Meal Tolerance Test (MMTT). It is used to calculate the Homeostasis Model Assessment (HOMA) and Matsuda Insulin Sensitivity Index

    Within 5 days after surgery or 5 days after start of caloric restriction

Other Outcomes (10)

  • Changes regarding markers of glucose metabolism

    Within 5 days after surgery or 5 days after start of caloric restriction

  • Changes of body weight

    Within 5 days after surgery or 5 days after start of caloric restriction

  • Changes of blood lipids

    Within 5 days after surgery or 5 days after start of caloric restriction

  • +7 more other outcomes

Study Arms (3)

LSG group

EXPERIMENTAL

Laparoscopic sleeve gastrectomy

Other: Laparoscopic sleeve gastrectomyOther: easy digestible diet

LRYGB group

EXPERIMENTAL

Laparoscopic Roux-en-Y gastric bypass

Other: Laparoscopic Roux-en-Y gastric bypassOther: easy digestible diet

Control group

OTHER

Caloric restriction

Other: Caloric restriction diet

Interventions

The surgical procedure and aftercare is indicated and performed according to the routine clinical setting of the Hospital. Patients stay 5 days stationary after surgical treatment. They receive a defined easy digestible diet, starting with liquid and mash food.

LSG group

The surgical procedure and aftercare is indicated and performed according to the routine clinical setting of the Hospital. Patients stay 5 days stationary after surgical treatment. They receive a defined easy digestible diet, starting with liquid and mash food.

LRYGB group

Patients of the control group do not undergo surgical treatment. They undergo a caloric restriction diet for 5 days. This diet is adapted to the postoperative diet of the patients included in the two other groups.

Control group
LRYGB groupLSG group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • BMI (Body Mass Index) ≥ 35 kg/m2
  • Clinical diagnosis of type II diabetes or impaired glucose metabolism (Prediabetes: HbA1c \> 5,7%, fasting glucose in capillary blood \> 110 mg/dl - diagnosed by blood glucose test at the first study examination)
  • Regarding the patients of the surgical groups: Indication to surgical therapy of obesity (laparoscopic sleeve gastrectomy or Roux-en-Y gastric bypass). The indication to surgery is independent of the study. The surgeon decides about that in the clinical routine according to the German S3 guideline.
  • Written consent to participate int he study

You may not qualify if:

  • Medication use which affects glucose metabolism, except for diabetes medication (for example: glucocorticoids)
  • Insulin need \>1,0 IU/kg/d
  • Experimental diabetes medication within the last three months
  • Pregnancy
  • Gastrointestinal diseases
  • Uncontrolled hypo- or hyperthyroidism
  • Status after bariatric or other gastrointestinal surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Hohenheim

Stuttgart, Germany

RECRUITING

MeSH Terms

Interventions

Caloric Restriction

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsEnergy IntakeDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Stephan C. Bischoff, Prof.

    Department of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany

    STUDY CHAIR
  • Alfred Königsrainer, Prof.

    Department of General, Visceral, and Transplant Surgery, University Hospital Tübingen, Germany

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2015

First Posted

September 17, 2015

Study Start

July 1, 2015

Primary Completion

May 1, 2019

Study Completion

July 1, 2019

Last Updated

May 17, 2018

Record last verified: 2018-05

Locations